West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. is a global leader in the design and manufacture of injectable pharmaceutical packaging and delivery systems, serving the pharmaceutical and healthcare industries. The company's core mission is to contain and deliver injectable therapies that improve patient lives, focusing on developing advanced containment and delivery systems for the safe and reliable administration of medicines worldwide. Headquartered in Exton, Pennsylvania, U.S., the company supports its global customer base from numerous locations across North and South America, Europe, Asia, and Australia.

West Pharmaceutical Services offers a comprehensive portfolio of products and services. Key offerings include elastomer-based packaging components such as stoppers, seals, and plungers, as well as non-glass containment solutions. The company also specializes in advanced drug delivery systems, including auto-injectors, prefillable systems, cartridge systems, self-injection systems, and wearable injectors like the SmartDose electronic wearable injector. Beyond products, West provides analytical lab services and contract manufacturing services, encompassing injection molding, assembly, and packaging, catering to the specific needs of pharmaceutical, biotechnology, and generic drug manufacturers.

In recent news, West Pharmaceutical Services reported strong first-quarter 2026 earnings and subsequently raised its full-year 2026 guidance, alongside authorizing a new $1 billion share repurchase program in April 2026. The company has experienced significant growth driven by increased demand for its higher-value injectable drug components, particularly GLP-1 elastomers and related contract manufacturing, which now constitute a notable portion of its revenue. Eric M. Green has served as President and CEO since April 2015 and as Chair of the Board since May 2022. The company announced leadership changes in April 2025, with Bernard J. Birkett stepping down as CFO and Shane Campbell appointed as Chief Proprietary Segment Officer.